Reaction
Blood Cholesterol Decreased reporting signals
As of the last recalculation, Blood Cholesterol Decreased appears in 1,838 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is INCLISIRAN (PRR 119.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Inclisiran | 81 | 119.6 | 120.8 |
| Evolocumab | 455 | 41.9 | 42.0 |
| Alirocumab | 82 | 38.7 | 38.8 |
| Isosorbide Mononitrate | 41 | 22.9 | 22.9 |
| Dextrose | 25 | 21.8 | 21.8 |
| Dextrose Monohydrate | 25 | 21.5 | 21.5 |
| Vortioxetine | 30 | 20.3 | 20.3 |
| Torsemide | 38 | 13.2 | 13.3 |
| Ezetimibe | 76 | 11.9 | 11.9 |
| Rosuvastatin | 169 | 10.2 | 10.2 |
| Ticagrelor | 28 | 10.1 | 10.1 |
| Pitavastatin Calcium | 9 | 10.0 | 10.0 |
| Felodipine Extended-Release Tablets | 10 | 10.0 | 10.0 |
| Felodipine | 10 | 10.0 | 10.0 |
| Niacin | 10 | 9.8 | 9.8 |
| Ezetimibe And Simvastatin | 13 | 9.7 | 9.8 |
| Linagliptin | 15 | 9.4 | 9.4 |
| Donepezil Hydrochloride | 29 | 9.1 | 9.1 |
| Hydroxyzine | 37 | 8.9 | 9.0 |
| Atorvastatin Calcium | 175 | 8.8 | 8.8 |
| Hydroxyzine Hydrochloride | 10 | 8.7 | 8.7 |
| Hydroxyzine Hydrochloride Oral | 10 | 8.7 | 8.7 |
| Exenatide | 38 | 8.3 | 8.3 |
| Metoclopramide | 36 | 7.6 | 7.6 |
| Sacubitril And Valsartan | 74 | 7.5 | 7.5 |
| Atorvastatin Calcium, Film Coated | 40 | 6.6 | 6.6 |
| Tramadol Hydrochloride | 21 | 6.4 | 6.4 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 6 | 6.2 | 6.2 |
| Dabigatran Etexilate | 41 | 6.1 | 6.1 |
| Prasugrel Hydrochloride | 5 | 5.6 | 5.6 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 5.3 | 5.3 |
| Crizotinib | 5 | 4.5 | 4.5 |
| Paliperidone | 6 | 2.9 | 2.9 |
| Orlistat | 6 | 2.6 | 2.6 |